Leonie Kubo
Family · Honolulu, HINPI 1568954899
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 226 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by Indivior Inc. at 24.5% of the total. Reporting peaked in 2023 at $1,616 and has fallen 51.6% since, to $782 in 2025. Among family clinicians in HI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 226 payments — averaging $24.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Indivior Inc.$1K
- Gilead$1K
- AbbVie$624
- Novo Nordisk$491
- Otsuka America Pharmaceutical, Inc.$452
- Teva Pharmaceuticals USA, Inc.$353
- plus $1K from 12 others
What the payments were for
- Food & beverage$5,449100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Indivior Inc. | 49 | $1,334 |
| Gilead | 95 | $1,031 |
| AbbVie | 19 | $624 |
| Novo Nordisk | 5 | $491 |
| Otsuka America Pharmaceutical, Inc. | 10 | $452 |
| Teva Pharmaceuticals USA, Inc. | 17 | $353 |
| Viiv Healthcare Company | 4 | $210 |
| Alkermes, Inc. | 5 | $189 |
| Madrigal Pharmaceuticals | 1 | $147 |
| Abbott | 2 | $135 |
| Amarin Pharma, Inc. | 2 | $120 |
| Johnson & Johnson | 5 | $107 |
| Lundbeck LLC | 4 | $78 |
| GSK | 3 | $70 |
| Lilly USA, LLC | 2 | $35 |
| Insulet Corporation | 1 | $27 |
| EMD Serono, Inc. | 1 | $25 |
| Exact Sciences | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$470
- PERSERIS$370
- ABILIFY MAINTENA$275
- ABILIFY ASIMTUFII$275
- RYBELSUS$235
- REZDIFFRA$147
- FreeStyle Libre 2$127
- Mavyret$125
- VRAYLAR$125
- APRETUDE$125
- Ozempic$122
- Epclusa$122
- UZEDY$119
How this compares
$5,449 in reported general payments places this provider in the 90th percentile of 466 family providers in Hawaii.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 68 | $66,877 |
| OzempicSemaglutide | 30 | $36,629 |
| TrulicityDulaglutide | 26 | $34,195 |
| RybelsusSemaglutide | 11 | $17,968 |
| Atorvastatin Calcium | 112 | $1,607 |
| Wixela InhubFluticasone Propion/Salmeterol | 12 | $1,364 |
| Testosterone | 15 | $1,304 |
| Amlodipine Besylate | 90 | $674 |
| Metoprolol Succinate | 51 | $637 |
| Tamsulosin Hcl | 44 | $632 |
| Gabapentin | 36 | $602 |
| Ibuprofen | 34 | $593 |
| Lisinopril | 67 | $580 |
| Omeprazole | 22 | $514 |
| Ketoconazole | 18 | $467 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $491 | $54,59841 claims |
| Lilly USA, LLCTrulicity | $35 | $34,19526 claims |
| Teva Pharmaceuticals USA, Inc.Acyclovir | $353 | $7513 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 466 family providers in Hawaii.
Other family in Honolulu
- Joey SesonHonolulu$48K
- Kanna DokgoHonolulu$26K
- John MosesHonolulu$24K
- Leif MarzHonolulu$11K
- Ia Lynne AranaHonolulu$9K
- Josette DudoitHonolulu$8K
- Kailie WongHonolulu$6K
- Jane StinsonHonolulu$6K
- Melissa leHonolulu$6K
- Karen RowanHonolulu$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.